In addition, another group discovered that miR-21 reduced inflammation, dysfunction, and myocardial remodeling after MI by targeting KBTBD7 and inhibiting the activation of p38 and NF-κB (15). The gene discussed is NFKB1; the disease is myocardial infarction.